Advancements in Neurodegenerative Disease Treatment

Sydney:

A group of Australian researchers has discovered small molecules that could prevent cell death, an encouraging step towards new treatments for neurodegenerative diseases like Parkinson’s and Alzheimer’s.

The team from the Walter and Eliza Hall Institute of Medical Research in Melbourne was focused on identifying new chemicals to help treat degenerative conditions.

These findings raise hopes for therapies that might slow down or halt the progression of neurodegenerative diseases.

After examining over 100,000 compounds, the researchers pinpointed a small molecule that targets a lethal protein known as Bax.

This molecule effectively hinders the action of well-known cell death proteins, thereby preventing cellular death.

“We were thrilled to discover a small molecule that focuses on Bax,” commented Professor Guillaume Lessene from WEHI.

“In most cells, the situation is different, but in neurons, simply turning off Bax might be sufficient to reduce cell death,” he added.

While treatments that induce cell death are making significant impacts in cancer therapies, developing blockers of cell death for neurodegenerative diseases has proven to be quite challenging.

The newly identified molecule targets Bax, which destroys cells by harming mitochondria, often considered the powerhouses of the cell.

“For the first time, I managed to displace Bax from mitochondria and used this molecule to keep the cells alive,” stated Kaiming Li, a leading researcher at Dewson Lab.

“This could open doors for next-generation inhibitors that combat degenerative diseases,” Li remarked.

The study has shown potential in identifying drugs that can prevent cell death, potentially paving a new way to develop essential treatments for conditions like Parkinson’s and Alzheimer’s, according to the researchers.